Phase 1 Immune response Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine
Vaccine ResponseImmune Response to Covid 19 VaccinationCOVID-19 vaccine
The Methodist Hospital Research Institute75 enrolled1 locationNCT06821100
Not Yet Recruiting
Phase 1
ProVac:Probiotic adjuvant to enhance the efficacy of pnemococcal vaccination: A pilot study.
Healthy infant immune response to the PCV13 pneumococcal vaccination
Associate Professor Mimi Tang30 enrolled1 locationACTRN12613000368730
Completed
Phase 1
Post-exercise Nutrition Recovery and Immune Response Study
Blood glucose and insulin and immune responses.
Dr Tracy Perry28 enrolled1 locationACTRN12605000168651